{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:49:04Z","timestamp":1758361744201,"version":"3.44.0"},"reference-count":12,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem. Pharm. Bull.","CHEMICAL &amp; PHARMACEUTICAL BULLETIN"],"published-print":{"date-parts":[[2025,9,18]]},"DOI":"10.1248\/cpb.c25-00382","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T22:08:08Z","timestamp":1758146888000},"page":"852-856","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the Film-Forming Ability for Heparinoid Cream Formulations"],"prefix":"10.1248","volume":"73","author":[{"given":"Niina","family":"Shikamura","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Teikyo Heisei University, 4\u201321\u20132 Nakano, Nakano-ku, Tokyo 164\u20138530, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Fukami","sequence":"additional","affiliation":[{"name":"Meiji Pharmaceutical University, 2\u2013522\u20131 Noshio, Kiyose, Tokyo 204\u20138588, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Koide","sequence":"additional","affiliation":[{"name":"Division of Drugs, National Institute of Health Sciences, 3\u201325\u201326 Tonomachi, Kawasaki-ku, Kawasaki 210\u20139501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Teikyo Heisei University, 4\u201321\u20132 Nakano, Nakano-ku, Tokyo 164\u20138530, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Nakajima K., Obata Y., Komine M., Aoyama Y., <i>Nippon Hifuka Gakkai Zasshi<\/i>, <b>134<\/b>, 1645\u20131655 (2024)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hirase R., Fujita T., Miyai T., Kawasaki H., Koseki H., <i>Exp. Dermatol.<\/i>, <b>33<\/b>, e70000 (2024).","DOI":"10.1111\/exd.70000"},{"key":"3","unstructured":"3) Asanuma Y., Kitahara R., Hayashida Y., Aoyama Y., <i>Nippon Hifuka Gakkai Zasshi<\/i>, <b>129<\/b>, 2165\u20132172 (2019)."},{"key":"4","unstructured":"4) Maruho Co., Ltd., \u201cPharmaceutical information and non-clinical trials for Hirudoid\u00ae Cream 0.3%\u201d https:\/\/www.maruho.co.jp\/medical\/articles\/hirudoid\/clinical_cream\/film_forming_capability.html."},{"key":"5","unstructured":"5) Maruho Co., Ltd., \u201cHirudoid\u00ae Cream 0.3%\/Hirudoid\u00ae Lotion\/Hirudoid\u00ae Soft Ointment 0.3%\/Hirudoid\u00ae Form 0.3% Interview form,\u201d 20th edition, 2025."},{"key":"6","unstructured":"6) Kenei Pharmaceutical Co., Ltd., \u201cHeparinoid Cream 0.3% \u300cKENEI\u300d Interview form,\u201d 1st edition, 2024."},{"key":"7","unstructured":"7) Yoshindo Inc., \u201cHeparinoid Cream 0.3% \u300cYD\u300d\/Heparinoid Lotion 0.3% \u300cYD\u300d\/Heparinoid Spray 0.3% \u300cYD\u300d Interview form,\u201d 4th edition, 2021."},{"key":"8","unstructured":"8) Rakool Pharmaceutical Marketing Co., Ltd., \u201cHeparinoid Cream 0.3% \u300cRakool\u300d\/Heparinoid Lotion 0.3% \u300cRakool\u300d Interview form,\u201d 5th edition, 2024."},{"key":"9","unstructured":"9) Nichi-iko Parmaceutical Co., Ltd., \u201cHeparinoid Cream 0.3% \u300cNichi-iko\u300d\/Heparinoid Lotion 0.3% \u300cNichi-iko\u300d Interview form,\u201d 12th edition, 2024."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Moll V., B\u2019ec K. B., Grabska J., Huck C. W.,  <i>Molecules<\/i>, <b>27<\/b>, 5882 (2022).","DOI":"10.3390\/molecules27185882"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yamamoto Y., Fukami T., Onuki Y., Metori K., Suzuki T., Koide T., <i>Vib. Spectrosc.<\/i>, <b>93<\/b>, 17\u201322 (2017).","DOI":"10.1016\/j.vibspec.2017.08.012"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yamamoto Y., Onuki Y., Fukami T., Koide T., <i>J. Pharm. Health Care Sci.<\/i>, <b>6<\/b>, 1 (2020).","DOI":"10.1186\/s40780-020-0158-y"}],"container-title":["Chemical and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpb\/73\/9\/73_c25-00382\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T04:04:07Z","timestamp":1758341047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpb\/73\/9\/73_c25-00382\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/cpb.c25-00382","relation":{},"ISSN":["0009-2363","1347-5223"],"issn-type":[{"type":"print","value":"0009-2363"},{"type":"electronic","value":"1347-5223"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"article-number":"c25-00382"}}